911069-07-3Relevant academic research and scientific papers
COMPOSITIONS AND METHODS FOR TREATING BRAIN INJURY
-
Page/Page column 97, (2019/04/11)
Compounds, and compositions, methods, and uses thereof, are described herein for treating brain injuries.
COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASES
-
Page/Page column 96, (2015/12/23)
Compounds, and compositions, methods, and uses thereof, are described herein for treating neurodegenerative diseases and disorders. In particular, vasopressin receptor modulators, and compositions, methods and uses thereof, are described herein for treati
BETA-LACTAM CANNABINOID RECEPTOR MODULATORS
-
Page/Page column 89-90, (2008/06/13)
Described herein are substituted 2-(azetidin-2-on-l-yl)alkanoic acids, alkanedioic acids and 2-hydroxyalkyl alkanoic acids, and 2-acyl alkanoic acids, and derivatives thereof, that are capable of modulating activity at the cannabinoid-1 (CBl) and/or canna
β -LACTAMYL VASOPRESSIN V2 ANTAGONISTS
-
Page/Page column 108, (2010/11/28)
β-lactamyl alkanoic acids and pharmaceutical compositions thereof are described. Methods for treating various diseases and disease states using one or more β-lactamyl alkanoic acids are also described. Substituted 2-(azetidin-2-on-l-yl)alkanedioic acids,
